Study on gene therapy for liver regeneration. -Effect of gene transduction of soluble HB-EGF and soluble TGF-β type II receptor on liver regeneration-
肝再生基因治疗研究-可溶性HB-EGF和可溶性TGF-βII型受体基因转导对肝再生的影响-
基本信息
- 批准号:13670517
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Acceleration of liver regeneration is important for the treatment of hepatic failure. We have reported that HB-EGF is a potent mitogen of hepatocyte and plays an important role in liver regeneratian. On the other hands, TGF-β, a growth inhibitory factor stimulates apoptosis of hepatocyte and inhibits liver regeneration.In this study, we demonstrated that NF-kB is activated in hepatic non-parenchymal cells after partial hepatectomy and stimulates the expression of HB-EGF gene. We also indicated that soluble form of HB-EGF is essential for liver regeneration using HB-EGF transgenic mice.To develop the new methods for acceleration the liver regeneration, dual introduction of soluble HB-EGF gene and soluble TGF-βtype II receptor that blocks the action of TGF-β is investigated. We developed the expression plasmid containing soluble TGF-βtype II receptor cDNA attached with human immunoglobulin Fc region or soluble HB-EGF cDNA. Both genes were introduced into mice skeletal muscle using in vivo electroporation methods. The plasma concentration of soluble HB-EGF and soluble TGF-β type II receptor were measured with newly developed ELISA systems. Pretreatment with hyaluronidase increased the expression levels and obtains 6-fold higher concentrations of soluble HB-EGF or soluble TGF-βtype II receptor.Our results give a basis for development of the gene therapy to accelerate the liver regeneration.
加速肝再生对于肝衰竭的治疗很重要。我们报道HB-EGF是一种有效的肝细胞有丝分裂原,在肝脏再生中发挥重要作用。另一方面,生长抑制因子TGF-β刺激肝细胞凋亡并抑制肝再生。在本研究中,我们证明部分肝切除术后肝非实质细胞中NF-kB被激活并刺激HB-EGF基因的表达。我们还表明,可溶性形式的 HB-EGF 对于 HB-EGF 转基因小鼠的肝再生至关重要。为了开发加速肝脏再生的新方法,研究了可溶性 HB-EGF 基因和阻断 TGF-β 作用的可溶性 TGF-β II 型受体的双重引入。我们开发了含有可溶性TGF-βII型受体cDNA并附有人免疫球蛋白Fc区或可溶性HB-EGF cDNA的表达质粒。使用体内电穿孔方法将这两种基因引入小鼠骨骼肌中。使用新开发的 ELISA 系统测量可溶性 HB-EGF 和可溶性 TGF-β II 型受体的血浆浓度。透明质酸酶预处理增加了表达水平,并获得了6倍高浓度的可溶性HB-EGF或可溶性TGF-βII型受体。我们的结果为开发加速肝脏再生的基因疗法奠定了基础。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
S. Sakuda, S. Tamura, A. Yamada, J. Miyagawa, K. Yamamoto, S. Kiso, N. Ito, K. Imanaka, A. Wada, T. Naka, T. Kishimoto, S. Kawata, Y. Matsuzawa: "Activation of signal transducer and activator transcription 3 and expression of suppressor of cytokine signal
S. Sakuda、S. Tamura、A. Yamada、J. Miyakawa、K. Yamamoto、S. Kiso、N. Ito、K. Imanaka、A. Wada、T. Naka、T. Kishimoto、S. Kawata、Y.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sakuta S, Tamura S et al.: "NF-kB activation in non-parenchymal liver cells after partial hepatectomy in rats : possible involvement in expression of heparin-binding epidermal growth factor-like growth factor"J. Hepatology. (in press). (2001)
Sakuta S、Tamura S 等人:“大鼠部分肝切除术后非实质肝细胞中 NF-kB 的激活:可能参与肝素结合表皮生长因子样生长因子的表达”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sakada S, Tamura S, et al.: "NF-kappaB activation an non-parenchymal liver cells after partial hepatectomy in rats : possible involvement in expression of heparin-binding epidermal growth factor-like growth factor"J Hepatol. 36・4. 527-533 (2001)
Sakada S、Tamura S 等人:“大鼠部分肝切除术后非实质肝细胞的 NF-kappaB 激活:可能参与肝素结合表皮生长因子样生长因子的表达”J Hepatol 36・4。 527-533 (2001)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
S.Sakuda, S.Tamura, et al.: "Activation of signal transducer and activator of transcription 3 and expression of suppressor of cytokine signal 1 during liver regeneration in rats"J. Hepatol.. 36. 378-384 (2002)
S.Sakuda、S.Tamura 等人:“大鼠肝再生过程中信号转导子和转录激活子 3 的激活以及细胞因子信号 1 抑制子的表达”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sakuta S, Tamura S et al.: "Activation of signal transducer and activator transcription 3 and expression of suppressor of cytokine signal 1 during liver regeneration in rats"J. Hepatology. (in press). (2001)
Sakuta S、Tamura S 等人:“大鼠肝再生过程中信号转导子和激活子转录 3 的激活以及细胞因子信号 1 抑制子的表达”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAMURA Shinji其他文献
TAMURA Shinji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAMURA Shinji', 18)}}的其他基金
Control of phase transition of the rare earth oxyfluorides
稀土氟氧化物的相变控制
- 批准号:
20K05077 - 财政年份:2020
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of the divalent cation conducting solid electrolytes
二价阳离子导电固体电解质的研制
- 批准号:
24750202 - 财政年份:2012
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Studies on High-valent Cation Conducting Solid Electrolytes
高价阳离子导电固体电解质的研究
- 批准号:
21750208 - 财政年份:2009
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Evaluation of novel metastasis-related genes and development of an early diagnostic marker in head and neck cancer
头颈癌新型转移相关基因的评估和早期诊断标记物的开发
- 批准号:
21592204 - 财政年份:2009
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A study of risk factors for intractable otitis media and nasopharyngeal transmission of causative pathogen
顽固性中耳炎危险因素及病原菌鼻咽传播的研究
- 批准号:
15591828 - 财政年份:2003
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A study of angiogenesis in head and neck cancers and its application to cancer gene therapy
头颈癌血管生成的研究及其在癌症基因治疗中的应用
- 批准号:
12671678 - 财政年份:2000
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on the gene therapy of soluble-HB-EGF gene to accelerate liver regeneration.
可溶性HB-EGF基因加速肝再生的基因治疗研究
- 批准号:
11670500 - 财政年份:1999
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effect of HB-EGF on liver regeneration in vovo and its application as a therapeutic agent.
HB-EGF 对体内肝再生的影响及其作为治疗剂的应用。
- 批准号:
09670544 - 财政年份:1997
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Examinational significance and production mechanism of a circulating soluble receptor for the diagnosis of activated adipocytes to prevent diabetes
循环可溶性受体对诊断激活脂肪细胞预防糖尿病的检测意义和产生机制
- 批准号:
16H05231 - 财政年份:2016
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional regulation of skeletal fiber due to fat-soluble receptor (GPCR) signaling
脂溶性受体 (GPCR) 信号传导对骨骼纤维的功能调节
- 批准号:
15K01741 - 财政年份:2015
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Treatment for fulminant hepatitis focusing on soluble receptor for HMGB1 (sRAGE)
暴发性肝炎的治疗重点是可溶性 HMGB1 受体 (sRAGE)
- 批准号:
26430093 - 财政年份:2014
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel soluble receptor-based therapy for Kidney Cancer
一种基于可溶性受体的新型肾癌疗法
- 批准号:
8751723 - 财政年份:2014
- 资助金额:
$ 1.92万 - 项目类别:
Molecular clarification of trans-differentiation to brown adipocytes through the action of soluble receptor LR11
通过可溶性受体 LR11 的作用对棕色脂肪细胞转分化的分子澄清
- 批准号:
24390231 - 财政年份:2012
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Soluble receptor activator of nuclear factor-kB ligand : involvement and significance as therapeutics in the osteolysis associated with breast cancer growth in the bone microenvironment
核因子-kB配体的可溶性受体激活剂:骨微环境中与乳腺癌生长相关的骨溶解的参与及其治疗意义
- 批准号:
21590442 - 财政年份:2009
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Soluble Receptor for AGEs in diabetes, platelet activation and atherosclerosis
糖尿病、血小板活化和动脉粥样硬化中 AGEs 可溶性受体
- 批准号:
17590946 - 财政年份:2005
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SOLUBLE RECEPTOR ANALOGS TO INHIBIT VEROTOXIN BINDING
抑制维罗毒素结合的可溶性受体类似物
- 批准号:
2668327 - 财政年份:1997
- 资助金额:
$ 1.92万 - 项目类别:
SOLUBLE RECEPTOR ANALOGS TO INHIBIT VEROTOXIN BINDING
抑制维罗毒素结合的可溶性受体类似物
- 批准号:
2882794 - 财政年份:1997
- 资助金额:
$ 1.92万 - 项目类别:
SOLUBLE RECEPTOR ANALOGS TO INHIBIT VEROTOXIN BINDING
抑制维罗毒素结合的可溶性受体类似物
- 批准号:
2017641 - 财政年份:1997
- 资助金额:
$ 1.92万 - 项目类别:














{{item.name}}会员




